Reply to 'Poor trial design leaves gene therapy death a mystery'.
Parker
H Stewart
HS
D026683:Advisory Committees; D018501:Antirheumatic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005260:Female; D015316:Genetic Therapy / Q000379:methods / Q000401:mortality*; D006660:Histoplasmosis / Q000401:mortality; D006801:Humans; D009316:National Institutes of Health (U.S.); D012107:Research Design; D014481:United States
D018501:Antirheumatic Agents